Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials

Cho‐Han Chiang, Furkan Bahar, Yu‐Cheng Chang, Tsu Hsien Wang, Yuan Ping Hsia, Cho‐Hung Chiang

Open source

DOI
10.1111/dom.70980
Published
2026-06-15
Container
Diabetes, Obesity and Metabolism
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.70980,
  title = {Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials},
  author = {Cho‐Han Chiang and Furkan Bahar and Yu‐Cheng Chang and Tsu Hsien Wang and Yuan Ping Hsia and Cho‐Hung Chiang},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.70980},
  url = {https://doi.org/10.1111/dom.70980}
}

RIS

TY  - JOUR
TI  - Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials
AU  - Cho‐Han Chiang
AU  - Furkan Bahar
AU  - Yu‐Cheng Chang
AU  - Tsu Hsien Wang
AU  - Yuan Ping Hsia
AU  - Cho‐Hung Chiang
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.70980
UR  - https://doi.org/10.1111/dom.70980
ER  - 

APA

Chiang, C., Bahar, F., Chang, Y., Wang, T. H., Hsia, Y. P., & Chiang, C. (2026). Semaglutide and Risk of Pancreatic Cancer: A Meta‐Analysis of Randomised Trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70980

Source records